Slovenia: Anjac Group takes step forward as CDMO with acquisition of Health Chain Group
Anjac Health & Beauty, a French family-owned industrial group specialising in the formulation, manufacturing and filling of cosmetics, medical devices, drugs, and food supplements,...
UK: T-Therapeutics’ Series A expanded to total of US$91m
T-Therapeutics, a UK-based biotechnology company focused on developing next-generation T cell receptor (TCR) therapeutics for cancer and autoimmune diseases, has announced the expansion of...
US: Galecto acquires Damora Tx and raises US$285m from Series C
Nasdaq-listed Galecto has completed the acquisition of Damora Therapeutics. Galecto, founded in 2011 by leading galectin scientists and biotech executives from Sweden, the UK, and...
UK: Warwick Capital Partners announces sale of Danforth Care Homes
Warwick Capital Partners, the UK-based global private equity and credit firm, has announced the sale of UK-based Danforth Care Homes. The divestment comes less...
Ireland: Lanas Healthcare Technology launches with US$115m M&A funding to drive global healthtech growth
Lanas Healthcare Technology, a new global healthcare technology platform, has officially launched following its acquisition of Clanwilliam Group, a leading provider of electronic health...
Sweden: EQT sets hard cap for EQT XI at €24bn
Swedish global investment firm, EQT, has set the hard cap for investor commitments of €24bn (US$27.74bn) for the EQT XI fund. The actual fund...
US: Pfizer to acquire Metsera for US$10bn as Novo Nordisk withdraws
Nasdaq-listed Metsera, a clinical stage biotech aiming to reduce the burdens of obesity, has agreed to an amended merger agreement with Pfizer whereby Pfizer...
Denmark: Impilo embarks on Oticon Medical carve out from Demant
Impilo, a Nordic investment company focused lower-mid-market Nordic healthcare companies, has agreed to acquire Oticon Medical, a Denmark-based global provider of bone-anchored hearing solutions...
France: Sandoz to boost in-house biosimilars capabilities with proposed acquisition of Just-Evotec Biologics EU...
Frankfurt-listed life science company Evotec has agreed to sell Just – Evotec Biologics Toulouse site to SIX-listed global generic and biosimilars company, Sandoz.
The proposed...
Switzerland: MoonLake Immunotherapeutics prices US$75m underwritten offer
Nasdaq-listed MoonLake Immunotherapeutics, a Switzerland-based clinical-stage biotechnology company focused on advancing therapies to address significant unmet needs in inflammatory skin and joint diseases, has...
Advertisement
